Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-17Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years [Phase 3]
Phase 3 trial evaluating immune response and safety of a combined diphtheria-tetanus-acellular pertussis vaccine (dTpa) in healthy Japanese …
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of Tdap vaccinations in plasma donors; results completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Establishing a Controlled Human Infection Model of Bordetella Pertussis [Phase 1]
Phase 1 clinical trial results establishing a controlled human infection model for Bordetella pertussis.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Safety Monitoring of VacPertagen Vaccine in Thailand
Safety monitoring update for the VacPertagen vaccine trial in Thailand investigating pertussis, with the study reported as completed and ong…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Maternal Determinants of Infant Immunity to Pertussis [Phase 4]
A Phase 4 clinical trial evaluated maternal factors that influence infant immunity to pertussis. The study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine [Phase 1]
This document reports the completion of the first adult safety trial (Phase 1) of an intranasal live attenuated Bordetella pertussis vaccine…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children [Phase 2]
Phase 2 trial assessing the immunogenicity and safety of the BPZE1 intranasal pertussis vaccine in healthy school-age children has completed…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers [Phase 2, Phase 3]
Immunogenicity results from Phase 2 and Phase 3 trials of a combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) vaccine in he…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand [Phase 3]
Phase 3 study evaluating the DTwP-HepB-Hib-IPV (SHAN6) vaccine administered with routine vaccines in healthy infants and toddlers in Thailan…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa [Phase 4]
This Phase 4 clinical trial assesses immune responses after a booster vaccination with Tdap-IPV in children who previously received differen…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine [Phase 3]
Phase 3 inter-lot consistency study update for an adsorbed cell-free diphtheria-tetanus-pertussis vaccine developed by CanSino Biologics.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors [Phase 2]
This Phase 2 clinical trial evaluated the safety and immunogenicity of Tdap vaccination in plasma donors. The study has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Immune Response followingTdap Vaccine in Pregnancy
This clinical trial update reports on the immune response following administration of the Tdap vaccine during pregnancy. The study, sponsore…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) [Phase 3]
Phase 3 clinical trial update for a diphtheria, tetanus and acellular pertussis vaccine adsorbed (DTcP) developed by CanSino Biologics; the …
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Pertussis Challenge Study in Adults Vaccinated With BPZE1 [Phase 2]
Phase 2 pertussis challenge study evaluating BPZE1 in adults has completed, with results posted. The trial assessed the vaccine's effect on …
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Increasing Influenza and Tdap Vaccination of Pregnant Women [NA]
A completed clinical trial aimed at increasing influenza and Tdap vaccination among pregnant women, with results posted in January 2025.
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Confirmatory Study of BK1310 in Healthy Infants [Phase 3]
A Phase 3 confirmatory trial of BK1310 in healthy infants evaluating protection against tetanus, diphtheria, pertussis, poliomyelitis, and b…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a diphtheria, tetanus, and pertussis vaccine in 3-month-old infants; currently …
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Maternal Pertussis Wholecell Responses [Phase 2]
Phase 2 clinical trial update assessing maternal pertussis whole-cell responses has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016) [Phase 4]
Phase 4 study assessing safety, tolerability, and immunogenicity of the hexavalent vaccine Vaxelis in children previously vaccinated with Va…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS [Phase 3]
Phase 3 trial update for a diphtheria-tetanus-acellular pertussis-inactivated poliovirus combination vaccine were completed.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults [Phase 2]
Phase 2 trial update for BPZE1 intranasal pertussis vaccine (Prime + Boost) in healthy adults; study completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the immunogenicity and safety of LBVD(Hexavalent Vaccine) in healthy infants as part of the primary seri…